The $14.50-per-share deal equates to a purchase price of $2.4 billion at closing, with Roche dangling another $6 per share in ...
Mash Mechanix Brewing Co. is teaming up with the Trails and Open Space Coalition (TOSC) for a fall celebration with a purpose. On Saturday, Sept. 20, from 5-10 p.m., the ...
GlobalData on MSN
Roche signs agreement to acquire 89bio in $2.4bn deal
Roche has signed a definitive merger agreement for the acquisition of clinical-stage biopharmaceutical company 89bio, for a ...
Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...
Roche inks merger agreement to acquire clinical-stage biopharma company, 89bio for up to US$ 3.5 billion: Basel Friday, September 19, 2025, 09:00 Hrs [IST] Roche announced that it ...
Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most prevalent comorbidities of obesityAcquisition supports Roche’s strategy as it enhances the company’s portfolio in ...
Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback